[{"id":"12f70933-9297-48d1-97e9-b55b4c2e9baa","acronym":"","url":"https://clinicaltrials.gov/study/NCT04363242","created_at":"2021-01-18T21:05:23.576Z","updated_at":"2024-07-02T16:35:50.740Z","phase":"Phase 1","brief_title":"A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions","source_id_and_acronym":"NCT04363242","lead_sponsor":"Synermore Biologics Co., Ltd.","biomarkers":" EGFR","pipe":" | ","alterations":" KRAS mutation • MSI-H/dMMR • EGFR expression","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • MSI-H/dMMR • EGFR expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SYN004 • SYN125"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 22","initiation":"Initiation: 04/09/2020","start_date":" 04/09/2020","primary_txt":" Primary completion: 07/31/2023","primary_completion_date":" 07/31/2023","study_txt":" Completion: 09/30/2023","study_completion_date":" 09/30/2023","last_update_posted":"2023-04-12"}]